Philip Astley-Sparke Insider Trading
Get free email notifications about insider trading for Philip Astley-Sparke.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Philip Astley-Sparke. Philip Astley-Sparke is a Director in uniQure N.V. ($QURE) and an Chief Executive Officer in Replimune Group, Inc. ($REPL) and an Executive Chairman in Replimune Group, Inc. ($REPL).
Address: C/O UNIQURE NV MEIBERGDREFF 61 AMSTERDAM 1005 BANetherlands
Companies in which Philip Astley-Sparke is an Insider
Replimune Group, Inc.
Trading Symbol: REPLIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Philip Astley-Sparke: Chief Executive Officer, Executive Chairman
Holdings: 1,340,712 shares
Latest Transaction: Apr 05 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
uniQure N.V.
Trading Symbol: QUREIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Philip Astley-Sparke: Director
Holdings: 9,946 shares
Current Value: $63,356
Latest Transaction: Mar 04 2021
$QURE Market Capitalization: $165.39M
$QURE Previous Close: $6.37
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Philip Astley-Sparke
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 05 2021 | REPL | Replimune Group, I ... | Astley-Sparke Philip | Chief Executive Off ... | Option Exercise | A | 31.58 | 128,125 | 4,046,188 | 128,125 | |
Apr 05 2021 | REPL | Replimune Group, I ... | Astley-Sparke Philip | Chief Executive Off ... | Grant | A | 0.00 | 85,415 | 0 | 1,340,712 | 1.3 M to 1.3 M (+6.80 %) |
Mar 04 2021 | QURE | uniQure N.V. | Astley-Sparke Philip | Director | Sell | S | 37.60 | 504 | 18,950 | 9,946 | 10.5 K to 9.9 K (-4.82 %) |
Jan 19 2021 | REPL | Replimune Group, I ... | Astley-Sparke Philip | Chief Executive Off ... | Sell | S | 42.40 | 7,632 | 323,597 | 1,255,297 | 1.3 M to 1.3 M (-0.60 %) |
Jan 19 2021 | REPL | Replimune Group, I ... | Astley-Sparke Philip | Chief Executive Off ... | Sell | S | 43.15 | 800 | 34,520 | 1,262,929 | 1.3 M to 1.3 M (-0.06 %) |
Jan 19 2021 | REPL | Replimune Group, I ... | Astley-Sparke Philip | Chief Executive Off ... | Sell | S | 43.02 | 9,409 | 404,775 | 1,263,729 | 1.3 M to 1.3 M (-0.74 %) |
Jan 19 2021 | REPL | Replimune Group, I ... | Astley-Sparke Philip | Chief Executive Off ... | Sell | S | 43.71 | 6,059 | 264,839 | 1,273,138 | 1.3 M to 1.3 M (-0.47 %) |